The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Expansion In Market Value Is Forecasted For The Nucleic Acid Labeling Market Between 2026 And 2030?
The nucleic acid labeling market size has shown strong growth over recent years. It is anticipated to expand from $2.77 billion in 2025 to $3.03 billion in 2026, growing at a compound annual growth rate (CAGR) of 9.4%. The historical growth within this sector can be attributed to several factors, including the limited availability of sensitive labeling reagents, low awareness regarding nucleic acid labeling applications, the high cost associated with instruments, a continued reliance on traditional labeling methods, and the slow adoption of high-throughput technologies.
The nucleic acid labeling market is projected to experience substantial growth in the coming years. By 2030, this market is anticipated to reach $4.42 billion, expanding at a compound annual growth rate (CAGR) of 9.9%. This expansion during the forecast period is driven by factors such as progress in fluorescent and non-radioactive labels, a surge in research and development within genomics and molecular diagnostics, the escalating need for high-throughput and multiplex assays, greater uptake in hospitals and diagnostic centers, and increased financial backing for research endeavors. Key trends anticipated for the forecast period encompass the increasing acceptance of nucleic acid labeling methods, the continuous evolution of sophisticated labeling kits and reagents, expanding utility in diagnostic and research domains, a heightened emphasis on multiplex and high-throughput labeling approaches, and the progressive integration of imaging and analytical instrumentation.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12647&type=smp
Which Key Factors Are Driving The Nucleic Acid Labeling Market Growth?
The anticipated increase in infectious diseases is projected to drive expansion within the nucleic acid labeling market moving ahead. Infectious illnesses are defined as conditions resulting from microscopic organisms, including parasites, fungi, viruses, and bacteria, which spread between individuals via direct or indirect interaction. For identifying infectious diseases like tuberculosis, hepatitis, and gonorrhea, nucleic acid labeling methods provide enhanced specificity, sensitivity, multiplexing capacity, visualization, real-time tracking, and automation. As an illustration, data from March 2024, provided by the Centers for Disease Control and Prevention, a US-based national public health agency, indicated that tuberculosis (TB) cases rose by 1,295, escalating from 8,320 in 2022 to 9,615 in 2023. This corresponds to an increase in the incidence rate, moving from 2.5 per 100,000 persons in 2022 to 2.9 per 100,000 in 2023, signifying a notable year-over-year increment. Consequently, the escalation in infectious diseases is a driving force behind the expansion of the nucleic acid labeling market.
Which Segment Types Are Examined In The Nucleic Acid Labeling Market Segment Study?
The nucleic acid labeling market covered in this report is segmented –
1) By Product Type: Kits, Reagents, Instruments
2) By Labeling Type: Radioisotope Or Radioactive Labels, Non-Radioactive Labels
3) By Method: Enzyme-Based, Chemical-Based
4) By Application: DNA Sequencing, Polymerase Chain Reaction, Fluorescence In Situ Hybridization (FISH), Microarrays, Blotting, In Situ Hybridization, Other Applications
5) By End-User: Hospitals Or Clinics, Diagnostic Centers, Other End-Users
Subsegments:
1) By Kits: DNA Labeling Kits, RNA Labeling Kits, Multiplex Labeling Kits
2) By Reagents: Labeling Reagents, Buffer Solutions, Conjugation Reagents
3) By Instruments: Nucleic Acid Analyzers, Microarray Processors, Imaging Systems
Which Trends Are Guiding The Direction Of The Nucleic Acid Labeling Market?
Leading companies in the nucleic acid labeling market are dedicating resources to enhance their market profitability. Investments in nucleic acid labeling involve financial contributions, funding, or capital injections provided by individuals, organizations, venture capitalists, or other entities into ventures, businesses, or projects centered on nucleic acid labeling technologies, as well as their research and development. For instance, in January 2023, Agilent Technologies Inc., a US-based supplier of software and instruments for laboratories, allocated $725 million to increase its therapeutic nucleic acids production capacity twofold, in response to the escalating demand for high-quality active pharmaceutical ingredients. This expansion, consistent with the company’s strategic concentration on growing markets, aims to satisfy the rising need for siRNA, antisense, and CRISPR guide RNA molecules employed in pharmaceuticals targeting various illnesses such as cancer, cardiovascular issues, and rare and infectious diseases.
Which Players Are Part Of The Competitive Landscape Of The Nucleic Acid Labeling Market?
Major companies operating in the nucleic acid labeling market are Thermo Fisher Scientific Inc., Merck Group, Roche Diagnostics Corporation, GE Healthcare Bio Sciences AB, Agilent Technologies Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Cytiva, Qiagen N.V., Biotium Inc., Illumina Inc., LGC Group, Promega Corporation, New England Biolabs, Enzo Biochem Inc., LI-COR Biosciences Inc., Eurogentec S.A., OriGene Technologies Inc., BaseClear B.V., Vector Laboratories Inc., Bio-Synthesis Inc., BioCat GmbH, Jena Bioscience GmbH, LubioScience GmbH, GeneCopoeia Inc., Mirus Bio LLC, Daicel Arbor Biosciences
Get The Full Nucleic Acid Labeling Market Report:
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Which Region Is The Largest In The Nucleic Acid Labeling Market?
North America was the largest region in the nucleic acid labeling market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nucleic acid labeling market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Nucleic Acid Labeling Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/nucleic-acid-labeling-global-market-report
Browse Through More Reports Similar to the Global Nucleic Acid Labeling Market 2026, By The Business Research Company
Genes Therapy Market Report 2026
https://www.thebusinessresearchcompany.com/report/genes-therapy-global-market-report
Oligonucleotides Therapy Market Report
https://www.thebusinessresearchcompany.com/report/oligonucleotides-therapy-global-market-report
Ribose Nucleic Acid Rna Based Therapeutics Market Report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model